The largest community of pharma leaders

Gary Jacobson Named President and Chief Financial Officer at Sinclair Research

COLUMBIA, Mo.–()–Sinclair Research, one of the leading providers of nonclinical research services, has named Gary Jacobson as President and Chief Financial Officer. In addition to his financial responsibilities, Gary will oversee Sinclair’s commercial, legal, human resources and IT functions.

“I’m delighted to welcome Gary to Sinclair,” said Sinclair Research CEO, Dr. Guy Bouchard, DVM. “Gary’s leadership experience in the CRO industry will help drive scalable and sustainable growth.”

“With the consolidation of the preclinical CRO industry, Sinclair is in a unique position to grow,” Jacobson said. “Sinclair has a scalable model and significant land to accommodate expansion. I’m impressed with Dr. Bouchard’s achievement here as well as the team of experienced scientific and business leaders he’s assembled, bringing backgrounds and perspective from large multi-national nonclinical CROs. My key focus will be to drive capital investment to support the expansion of our nonclinical services and capacity so we can grow our offering as a single site.”

Prior to Sinclair, Gary was President, Chief Executive Officer and Chief Financial Officer of SNBL USA, Ltd. where he led the effort to turnaround that North American preclinical CRO. He was principal and director of General Biotechnology, LLC, and previously served as Executive Vice President and Chief Financial Officer at Ricerca Biosciences, Executive Vice President and Chief Financial Officer of Harlan Sprague Dawley, Inc. and Chief Operating Officer of Harlan Europe. Gary began his career in the banking industry serving as Senior Vice President and Division Manager of LaSalle National Bank and Senior Vice President of American National Bank.

About Sinclair Research

Sinclair Research Center, a nonclinical contract research organization (CRO), offers animal efficacy models, pharmacokinetics/pharmacodynamics evaluation, IND-enabling program support and specialty toxicology research capabilities to support biopharmaceutical, animal health and medical device development programs. Sinclair is experienced in all research models and the undisputed experts in miniature swine. With more than 50 years’ experience, Sinclair has emerged as a leader in diabetes, dermal, otic and animal health research services with streamlined quality systems supporting both VICH and GLP compliant studies and SEND reporting with no backlog.

Read More

0FansLike
0FollowersFollow
0FollowersFollow
0FollowersFollow

Recent Articles

Face Masks Disrupting Effective Communication for Those With Hearing Loss

MINNEAPOLIS--(BUSINESS WIRE)--The COVID-19 pandemic continues to change the way we all...

Packaging Technology Group (PTG) Completes Its Line of Thermally Pre-Qualified 2-8°C Shipping Solutions for Vaccines and Biologics

BOSTON--(BUSINESS WIRE)--Packaging Technology Group, Inc (PTG), a leading provider of thermal...

Gilead Sciences Update on Supply and Distribution of Veklury® (remdesivir) in the United States

FOSTER CITY, Calif.--(BUSINESS WIRE)--Since the COVID-19 pandemic began, Gilead has worked...

JEOL Strengthens European Business in the Medical Equipment Segment

TOKYO--(BUSINESS WIRE)--JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) has opened...

Thomas Health Emerges From Bankruptcy, Keeps Hospitals Open

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--At a time when hospitals are hardest hit,...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.